全球免疫組織化學市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計到 2034 年，免疫組織化學市場規模將達到 67.7 億美元，高於 2025 年的 36.8 億美元，預計從 2026 年到 2034 年，複合年成長率將達到 7.01%。

由於癌症和感染疾病對精準診斷技術的需求不斷成長，全球免疫組織化學市場正在擴張。免疫組織化學（IHC）廣泛應用於病理學，用於檢測組織內的特定抗原，從而輔助疾病的診斷和研究。全球癌症發生率的不斷上升是推動市場成長的主要因素。

關鍵促進因素包括染色技術的進步、生物標記應用的增加以及個人化醫療研究的活性化。製藥公司正在藥物研發和臨床試驗中應用免疫組織化學技術。此外，檢查室自動化程度的提升也提升了效率和可靠性。

由於與數位病理學和人工智慧影像分析的融合，該市場預計擁有光明的前景。對醫療基礎設施和研究活動的投入增加將進一步推動其成長。隨著精準醫療的不斷發展，免疫組織化學仍將是診斷和研究中不可或缺的工具。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球免疫組織化學市場：依產品分類

• 市場分析、洞察與預測
• 抗體
• 試劑
• 成套工具
• 裝置

第5章 全球免疫組織化學市場：依應用分類

• 市場分析、洞察與預測
• 診斷
• 出於研究目的
• 法醫學

第6章 全球免疫組織化學市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院和診斷檢查室
• 研究機構和學術機構
• 其他

第7章 全球免疫組織化學市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • PHC Holdings Corporation
  • Biogenex Laboratories
  • Thermofischer Scientific Inc
  • Sakura Finetek Japan Co. Ltd
  • Elabscience Inc
  • Cell Signaling Technology Inc
  • Eagle Biosciences Inc
  • CANDOR Bioscience GmbH
  • Merck Kgaa
  • Agilent Technologies Inc

The Immunohistochemistry Market size is expected to reach USD 6.77 Billion in 2034 from USD 3.68 Billion (2025) growing at a CAGR of 7.01% during 2026-2034.

The global immunohistochemistry market is expanding due to increasing demand for accurate diagnostic techniques in cancer and infectious diseases. Immunohistochemistry (IHC) is widely used in pathology to detect specific antigens in tissues, aiding in disease diagnosis and research. The rising incidence of cancer globally is a major factor driving market growth.

Key drivers include technological advancements in staining techniques, increasing use of biomarkers, and growing research in personalized medicine. Pharmaceutical companies are leveraging IHC for drug development and clinical trials. Additionally, improvements in laboratory automation are enhancing efficiency and reliability.

The future of the market looks promising with the integration of digital pathology and AI-based image analysis. Increasing investments in healthcare infrastructure and research activities will further support growth. As precision medicine continues to evolve, immunohistochemistry will remain a vital tool in diagnostics and research.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Antibody
• Reagents
• Kits
• Equipment

By Application

• Diagnosis
• Research Applications
• Forensic

By End User

• Hospital and Diagnostic Labs
• Research Institutes and Academic Institutes
• Others

COMPANIES PROFILED

• PHC Holdings Corporation, Biogenex Laboratories, Thermofischer Scientific Inc, Sakura Finetek Japan Co Ltd, Elabscience Inc, Cell Signaling Technology Inc, Eagle Biosciences Inc, CANDOR Bioscience GmbH, Merck Kgaa, Agilent Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Antibody Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Research Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Forensic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospital and Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Research Institutes and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IMMUNOHISTOCHEMISTRY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 PHC Holdings Corporation
  • 9.2.2 Biogenex Laboratories
  • 9.2.3 Thermofischer Scientific Inc
  • 9.2.4 Sakura Finetek Japan Co. Ltd
  • 9.2.5 Elabscience Inc
  • 9.2.6 Cell Signaling Technology Inc
  • 9.2.7 Eagle Biosciences Inc
  • 9.2.8 CANDOR Bioscience GmbH
  • 9.2.9 Merck Kgaa
  • 9.2.10 Agilent Technologies Inc